Open access peer-reviewed chapter

Natural Products for Preventing and Controlling Aflatoxin Contamination of Food

Written By

Fei Tian and Hyang Sook Chun

Submitted: 26 November 2016 Reviewed: 08 March 2017 Published: 30 August 2017

DOI: 10.5772/intechopen.68413

From the Edited Volume

Aflatoxin - Control, Analysis, Detection and Health Risks

Edited by Lukman Bola Abdulra'uf

Chapter metrics overview

3,623 Chapter Downloads

View Full Metrics


Aflatoxins are the most potent naturally occurring toxin and liver carcinogens known and their contamination of food is a significant risk factor for human health. Conventional chemical and physical approaches have been insufficient to eliminate aflatoxins from food, and the application of synthetic compounds can give rise to notable drug resistance and serious environmental and health problems. Awareness of these problems has led to an urgent need to identify safer alternative strategies. There are various natural compounds that influence aflatoxin contamination of food in different ways, including by inhibiting the growth of aflatoxigenic fungi, blocking aflatoxin biosynthesis, and removing or degrading aflatoxins. These inhibitors, many of which have shown great potentials for the control of aflatoxin contamination, have great promise for the development of new approaches to combatting aflatoxin contamination, and are capable of replacing or complementing conventional strategies. While more and more natural inhibitors are being identified, the modes of action of most of these are poorly understood. Further studies are necessary to better understand the mechanism of action of these compounds before their widespread commercial use. The objective of this chapter is to present the results of studies of the control of aflatoxin contamination using natural products.


  • aflatoxin
  • natural products
  • antifungal
  • antiaflatoxigenic
  • detoxification

1. Introduction

Aflatoxins are a group of toxic secondary metabolites synthesized by fungi of the Aspergillus species, particularly A. flavus and A. parasiticus [1]. They are the most widely distributed soil‐borne molds on earth and are capable of surviving on many organic nutrient sources, including stored grains and fodders, dead plants, insect and animal carcasses, and even immunocompromised humans and animals [2]. When grown under appropriate conditions, these fungi exist in the form of mycelia or conidia (asexual spores), while under adverse conditions such as a lack of nutrients or water, their fungal mycelium will transform to resistant structures known as sclerotia, which can survive in extremely harsh environmental conditions [3]. Aflatoxin‐producing fungi affect many agricultural crops such as rice, corn, wheat, peanuts, and chilies. Pre‐ and post‐harvest contamination of these crops with aflatoxins is common and annually causes great economic loss [4, 5].

Aflatoxins were first identified in 1960 in England as the cause of the Turkey X disease [6]. There are four major aflatoxins produced in nature: B1, B2, G1, and G2. They are named based on their fluorescence under ultraviolet light, and their relative mobility in thin‐layer chromatography on silica gel. Most A. flavus produce aflatoxins B1 and B2, whereas A. parasiticus produce aflatoxins B1, B2, G1, and G2. Aflatoxin M1 is another frequently detected aflatoxin in nature; it is a hydroxylated derivative metabolized by cows from aflatoxin B1 and secreted in milk [7].

Aflatoxins are the most potent naturally occurring toxins and liver carcinogens known, and their contamination of food is a significant risk factor for human health, particularly in developing countries that lack detection, monitoring, and regulating measures to safeguard the food supply. It has been reported that approximately 4.5 billion people living in developing countries are chronically exposed to uncontrolled amounts of aflatoxins [7]. Long‐term low‐dose dietary exposure to aflatoxins is also a major risk for hepatocellular carcinoma. Aflatoxins have been designated as human liver carcinogens by the International Agency for Research on Cancer [8]. Therefore, the control and elimination of aflatoxigenic fungi and aflatoxins in food have great significance. To minimize potential exposure to aflatoxins, maximum levels of aflatoxins have been established by different countries [9]. The U.S. Food and Drug Administration specified a maximum of 20 ppb total aflatoxins for interstate trading of food and feedstuffs and 0.5 ppb aflatoxin M1 in milk. The European Commission has set the limits on cereals and derived products at 4 ppb for total aflatoxins and 2 ppb for aflatoxin B1, and for nuts and dried fruits subject to further processing at 10 ppb for total aflatoxins and 5 ppb for aflatoxin B1. The Korea Ministry of Food and Drug Safety imposed limits for aflatoxin B1 of 10 ppb and total aflatoxins of 15 ppb.

Chemical and physical approaches are widely used to minimize the risk of aflatoxin contamination of food. These are usually focused on inhibiting the development of spores and mycelia, and/or inactivation of aflatoxins by their transformation to nontoxic compounds. The most common methods include the use of synthetic fungicides, X‐radiation, dehulling or cooking processes, and control of environmental factors during harvest and storage [10, 11]. These strategies are usually expensive, time‐consuming, and inefficient. Some of them also cause major changes in the physical properties of food and a serious loss of nutritive value and therefore are inappropriate to eliminate aflatoxins from food [12]. Synthetic chemicals are still the most widely used recourse to prevent fungal contamination of food crops. However, there are strict regulations on chemical compound use in food, and there is political pressure to remove hazardous chemicals from the market [13]. In addition to these limitations, the application of synthetic fungicides can also give rise to notable drug resistance and serious environmental and health problems [14]. Awareness of these problems has led to an urgent need to identify safer alternative strategies.

Natural products are chemical compounds or substances produced by a living organism, and their use as biocontrol agents provides an opportunity to avoid synthetic fungicides. Over the years, efforts have been made to identify new antifungal materials from natural sources for controlling aflatoxin contamination of food [15]. Many bacteria, fungi, and plants that share ecological niches with and encounter aflatoxigenic fungi have the ability to synthesize compounds that inhibit aflatoxin synthesis or remove aflatoxins from food without significant losses in nutritive value; they therefore could be used to replace or complement conventional strategies. Basically, there are three possible ways of using natural products to avoid the harmful effects of aflatoxin contamination of food and feed: (1) prevent and control aflatoxigenic fungus contamination (fungal growth inhibition), (2) inhibit aflatoxin biosynthesis (aflatoxin production inhibition), and (3) decontamination of aflatoxin‐containing food and feed (aflatoxin detoxification). These microbial metabolites and plant constituents are natural products and therefore are desirable for use in food because they can be easily degraded in nature. A variety of naturally derived compounds have been studied for their antifungal and antiaflatoxigenic activities, many of which have shown great potential for controlling aflatoxin contamination. The objective of this chapter is to present the results of studies of the control of aflatoxin contamination using natural products from bacteria, fungi, and plants.


2. Fungal growth inhibition

Fungi of Aspergillus sp. are the only source of aflatoxin contamination in food. The production of aflatoxin is greatly dependent on the growth condition of Aspergillus fungi; thus, it can be suppressed effectively through inhibit fungal growth. Many compounds produced by bacteria, fungi, and plants are possessed of abilities to inhibit fungal growth at different levels, such as inhibit conidia production and germination, interrupt membrane formation, or damage cell membrane, and disrupt fungal mitochondria (Table 1).

Target of actionAntifungal productSourceActivity againstReference
Conidia production and/or germinationAegle marmelos essential oilA. marmelos (leaves)Alternaria sp., Colletotrichum sp., Curvularia sp., Ustilago sp.[16]
Aldehydes (C6)Plants1Alternaria sp., Botrytis sp.[17]
(E)‐Anethole, p‐anisaldehyde, carvacrol, (−)‐carvone, 1,8‐cineole, (+)‐limonene, myrcene, (±)‐α‐phellandrene, (±)‐α‐pinenePlantsBotrytis sp., Monilinia sp., Mucor sp., Penicillium sp., Rhizopus sp.[18]
BenzaldehydePlantsMonilinia sp., Botrytis sp.[19]
ChitosanPlantsBotrytis sp., Rhizopus sp.[20]
FusapyroneFusarium semitectumBotrytis sp.[21]
1‐Octen‐3‐olP. paneumPenicillium sp.[22]
TerpenoidNasutitermes sp.Metarhizium sp.[23]
Membrane formation and/or integrityBrefeldin AEupenicillium brefeldianumPisolithus sp.[24]
Carvacrol, thymolPlantsCandida sp.[25]
Clove essential oilSyzygium aromaticumCandida sp., Aspergillus sp. dermatophyte fungi[26]
DefensinsPlantsNeurospora sp., Saccharomyces sp.[27]
Eugenol, methyl eugenolPlantsCandida sp.[28]
GeraniolPlantsCandida sp., Saccharomyces sp.[29]
Ocimum sanctum essential oilO. sanctumCandida sp.[30]
OsmotinTobaccoAspergillus sp., Rhizoctonia sp., Macrophomina sp., Bipolaris sp., Fusarium sp., Phytophthora sp., Trichoderma sp.[31]
PhytochemicalsThymus vulgaris L.Rhizopus sp.[32]
ZeamatinZea maysCandida sp., Neurospora sp., Trichoderma sp.[33]
Cell organelles functionCruentarenByssovorax cruentaCandida sp., Metschnikowia sp., Saccharomyces sp., Rhodotorula sp., Botrytis sp., Mucor sp., Rhizopus sp.[34]
DefensinPlantsCandida sp.[35]
Anethum graveolens essential oilA. graveolens L.Aspergillus sp.[36]
HaliangicinHaliangium luteumAspergillus sp., Botrytis sp., Fusarium sp., Mucor sp., Pythium sp., Saprolegnia sp.[37]
PhytoalexinsMusa acuminataCladosporium sp., Pyricularia sp., Plasmopara sp., Sphaeropsis sp.[38]
Plagiochin EMarchantia polymorpha L.Candida sp.[39]
PyrrolnitrinBurkholderia cepaciaStreptomyces sp.[40]
Tagetes patula essential oilT. patula L.Botrytis sp., Penicillium sp.[41]
UK‐2A, UK‐3AStreptomyces sp.Saccharomyces sp.[42]

Table 1.

Natural products against fungal growth.

1 Natural product exists in different plants.

The use of bacteria is a promising solution to alleviate fungal contamination in food. In recent years, the study and application of antifungal bacteria has received strong interest. Significant progress has been reported on the isolation and characterization of antifungal compounds. Various bacterial compounds including organic acids, phenyllactic acids, reuterin, and cyclic dipeptides, proteinaceous compounds, and fatty acids have been reported to be able to inhibit the growth of aflatoxigenic fungi (Table 2).

StrainActivity againstInhibitory compoundTarget of actionReference
Amorphophallus campanulatus (Roxb)A. flavusAmblyoneUnknown[43]
Bacillus subtilis AU195A. flavusBacillomycin DConidial germination[44]
B. pumilusA. parasiticusCyclic polypeptideUnknown[45]
B. subtilis KS03A. flavus, A. parasiticusIturin ACell surface hydrophobicity[46]
B. subtilis YM 10‐20A. flavusIturin‐like compoundConidial germination[47]
Humicola fuscoatra NRRL 22980A. flavus.Monorden, monocillin IV, cerebrosidesUnknown[48]
Lactobadllus casei subsp. pseudoplantarumA. flavusProteinaceousUnknown[49]
Lactococcus lactis ATCC 11454A. flavusHeat‐stable low‐molecular weight compoundsUnknown[50]
Lb. casei subsp. pseudoplantarumA. flavusProteinaceousUnknown[51]
Lb. casei subsp. pseudoplantarum 371A. parasiticusProteinaceousUnknown[52]
Lc. lactis subsp. diacetylactis DRC1A. flavusProteinaceousConidial germination[53]
Lc. lactis subsp. lactis CHD28.3A. flavus, A. parasiticusProteinaceousUnknown[54]
Pseudomonas aeruginosa K‐187A flavus, A. parasiticusPafunginHyphae lysis[55]
Streptomyces sp. DPTB16A. flavus4′‐Phenyl‐1‐napthyl‐phenyl acetamideUnknown[56]
Streptomyces sp. MRI 142A. parasiticusAflastatinUnknown[57]
S. albidoflavus ANU 6277A. flavus3‐Phenylpropionic acidUnknown[58]

Table 2.

Antifungal compounds against aflatoxigenic fungi growth.

Many bacteria produce organic acids such as lactic, acetic, and propionic acids. The production of these weak organic acids results in an acidic environment that generally restricts the growth of both bacteria and fungi [59]. Phenyllactic acid has been widely reported to have antifungal activities, and its broad‐spectrum antibacterial and antifungal action makes it one of the most extensively studied antifungal organic acids derived from bacteria. Over the last decade, a number of studies have identified phenyllactic acid as the causative agent of antifungal activity. Its lack of toxicity to both animals and humans body, and its lack of any smell make phenyllactic acid a potential candidate for the control of food spoilage [60]. In addition, phenyllactic acid can also play a synergistic role with other metabolites [61, 62]. Reuterin is another antifungal compound produced by bacteria. This low‐molecular‐weight compound has also been reported to possess broad‐spectrum antimicrobial activity. It has been demonstrated to be capable of inhibiting the growth of a wide range of molds including A. flavus [63]. Some fatty acids produced by bacterial strains have also received great attention for their antifungal properties. For example, 2‐hydroxy‐4‐methylpentanoic acid produced by Lactobacillus plantarum VE56 and Weissella paramesenteroides LC11 is thought to act in synergy with other inhibitory metabolites and was shown to cause growth arrest in Aspergillus species [64]. Peptides inhibiting fungal growth have also been isolated from some bacterial strains. For example, Garofalo et al. demonstrated the existence of a series of peptides responsible for the antifungal activity of Lb. rossiae LD108. These peptides induced a clear delay in fungal growth on different bakery products, and were shown by Matrix assisted laser desorption/ionization time‐of‐flight mass spectrometric analysis to cause gluten proteolysis [65].

Fungal metabolites have also been used to reduce aflatoxin contamination in various crops. A recent study showed that culture filtrates of Trichoderma spp. at 200 mL/kg showed 72–93% inhibition of mycelial growth of A. flavus [66]. Nakaya reported the production of a small basic antifungal protein by the mold A. giganteus [67], and thoroughly characterized the structure of this protein as a highly twisted β‐barrel stabilized by four internal disulfide bridges, which resembles the structure of some antifungal polypeptides produced by plants, such as defensins and thionins [68]. Similar proteins with high sequence homology have been described in other fungi, such as Aspergillus niger and Penicillium chrysogenum [69]. It is possible that the production of these antifungal proteins provides the producer with a competitive advantage against other fungal strains in the same environment.

Plants lack an immune system and must depend on other mechanisms to defend themselves against fungal invaders. One such mechanism is the synthesis of bioactive compounds that act specifically to inhibit fungal growth. Many plant extracts, particularly essential oils, have been reported to possess significant antifungal activity. An extract of Azadirachta indica was observed to be a good inhibitor of the growth of both A. flavus and A. parasiticus in vitro [70], and the oil from Ocimum canum exhibited activity against a broad range of fungi, including aflatoxin‐producing fungi [71]. Several peptides and proteins are also associated with the antifungal activity of plants. Huang et al. reported that the grains of Tex6 wheat contain zeamatin, a thaumatin‐like protein belonging to the PR5 group of pathogen related proteins, which inhibits the growth of A. flavus [72]. Chen et al. identified a 14‐kDa protein that was present in resistant maize genotypes but in only a very low concentration in susceptible genotypes. This protein was identified as a trypsin inhibitor that also inhibited conidial germination and hyphal growth of A. flavus. Further studies showed that this protein inhibits the α‐amylase from A. flavus [73]. Chitin is a common constituent of fungal cell walls. All organisms that contain chitin also contain chitinases (EC, which are presumably required for morphogenesis of cell walls [74]. Other organisms that do not contain chitin may produce chitinases to degrade the polymer for food. Plants have also been found to contain chitinase. Because plants do not contain chitin in their cell walls, it has been postulated that they produce chitinase to protect themselves from chitin‐containing parasites including fungi [75]. Roberts and Selitrennikoff reported the isolation of a chitinase from barley grain that acting alone could inhibit fungal growth [76]. The antifungal activity of bacterial chitinases was also investigated, because plant and bacterial chitinases differ markedly in their antifungal activity, and this difference in biological activity correlates with differences in their substrate specificities [77]. Seeds of many plants contain high concentrations of chitinases, glucanases, and ribosome‐inactivating proteins that may help protect seeds and seedlings from fungal infection [78]. One study showed that a maize chitinase preparation was highly active and caused a 100‐fold reduction in the minimum dose of nikkomycin required to inhibit fungal growth [79]. Careful analysis of the maize preparation revealed several proteins and several enzyme activities. Further study revealed that zeamatin, a 22‐kDa protein, is responsible for this synergistic activity, and showed that zeamatin exerts its antifungal effects by damaging fungal membranes [33].

Antifungal peptides and proteins have also been found in insects. Cecropins, originally isolated from the immune hemolymph of the Cecropia moth, are a key component of the immune response in insects. They have been shown to possess strong inhibitory activity against fungal growth. It has been reported that the structural features of the cecropins include a strongly basic N‐terminus, an intermediate hinge region containing glycine and/or proline, and a hydrophobic C‐terminus, which are all necessary for its lethal activity. Studies suggested that the fungicidal activity of cecropins is mediated by the formation of pores across cell membranes that lead to leakage of cytoplasmic contents and ultimately to cell death [80]. In addition, Powell et al. found that one kind of cecropin, cecropin B, can inhibit fungal growth by suppressing the germination of fungal conidia [81]. Consequently, these peptides have been studied for engineering fungal disease resistance in plants.


3. Aflatoxin production inhibition

One important side effect of fungal growth inhibition is the rapid spread of resistant strains. Therefore, inhibitors of aflatoxin production may be a better choice for control and prevention of aflatoxin contamination of food. Current methods to control aflatoxin contamination are mainly based on chemical strategies (pesticides and fungicides). However, the excessive use of chemical treatments has many undesirable consequences: (1) marked pollution of the environment, (2) an increase in resistant pathogen populations, and (3) the presence of chemical residues in food. Specific microbial metabolites and plant constituents have been shown to be effective inhibitors of aflatoxin production without significantly affecting fungal growth; in fact, numerous compounds and extracts possessing inhibitory activity for aflatoxin biosynthesis have been reported. However, tools and techniques have only recently become available to investigate the molecular mechanisms by which these inhibitors regulate aflatoxin biosynthesis [82].

Microbially derived inhibitors of aflatoxin production are of practical use because of their strong activity and the possibility of large‐scale production. For example, a number of Lentinula edodes isolates are able to inhibit aflatoxin production and the isolate CF42 shows significant inhibitory activity. This effect is probably the result of the presence in the extracts of a number of different compounds with different inhibitory strategies. This is supported by the results obtained with fractionation of L. edodes CF42 filtrates, which leads to a decrease in their inhibitory effect but not to a complete loss of effect. Reverberi and coworkers also reported that culture filtrates of L. edodes isolate CF42 are able to inhibit aflatoxin production. L. edodes is able to release and accumulate lentinans and other β‐glucans in the culture media. A recent study reported a direct relationship between aflatoxin inhibition and the β‐glucan content of lyophilized L. edodes filtrates, suggesting that β‐glucans could be amongst the factors responsible for their inhibitory effect on aflatoxins [83]. The ability of fungal β‐glucans to act as free radical scavengers was recently shown in animal models [84]. In vivo research showed that glucans and glycoproteins extracted from fungi protect macrophages from the damage caused by lipoperoxide accumulation, mainly by activating the transcription of genes related to the macrophage antioxidant system [85]. Because the molecular analyses carried out on A. parasiticus mycelia treated with CF42 filtrates showed a significant activation of hsf2‐like transcription factors of the fungal antioxidant system, a similar effect on macrophages could be hypothesized. It could be suggested that culture filtrates of L. edodes interfere with the cascade of signals that allows aflatoxin biosynthesis. It has also been hypothesized that accumulated β‐glucans in the culture filtrates of L. edodes are able to inhibit aflatoxin production by A. parasiticus through the enhancement of the internal antioxidant system. Lyophilized filtrates of L. edodes could be applied alone or in association with other food‐grade compounds, to prevent aflatoxin production in food and feed [86]. In addition, the polysaccharides of this basidiomycete have low cytotoxicity for animal cells and could contribute to the nutritive value of the food or feed supplemented with these extracts [87].

Plant‐derived inhibitors of aflatoxin production have great potential because not only are they highly effective but also the genes responsible for their biosynthesis could be transferred into susceptible host plants to create transgenic plants that resist aflatoxin contamination by in situ production of aflatoxin production inhibitors. For example, gallic acid is an effective plant‐derived compound that inhibits aflatoxin production by A. flavus and disrupts expression of early and late aflatoxin biosynthesis genes. Evidence suggests that its aflatoxin production inhibitory activity may correlate with its strong antioxidant activity [82]. Transgenic plants with elevated levels of gallic acid that suppress aflatoxin production have been created [88]. Many essential oils obtained from parts of higher plants have also been shown to possess antiaflatoxigenic properties [89]. Various individual and combined plant extracts have been evaluated for their efficacy against aflatoxin production in vitro. For example, Satureja hortensis L. essential oil was found to inhibit production of aflatoxin B1 and G1 by A. parasiticus. The aflatoxin‐production inhibitors were separated using reverse‐phase high‐performance liquid chromatography and finally identified as carvacrol and thymol. Further testing revealed that both carvacrol and thymol were able to effectively inhibit production of aflatoxin B1 and G1 in a dose‐dependent manner [90].

In principle, there are three possible ways to inhibit aflatoxin biosynthesis (Figure 1). First, there can be alteration of the physiological environment or disturbance of the signaling inputs perceived by the fungus. For example, eugenol is a major phenolic component of essential oils extracted from cloves, cinnamon, and nutmeg. It has been shown in multiple experiments to inhibit aflatoxin biosynthesis. Evidence suggests that eugenol inhibits aflatoxin biosynthesis by lowering the physiological requirement for the enzymes activities involved in responding to oxidative stress. Eugenol treatment of fungi growing on Potato Dextrose Agar plates has been shown to result in the reduction of enzyme activities (glutathione peroxidase, microsomal reductases, superoxide dismutase, and xanthine oxidase) involved in responding to oxidative stress, concomitant with the inhibition of aflatoxin production by up to 50% [91]. Zingerone is another plant‐derived aflatoxin inhibitor isolated from certain parts of Zingiber officinale or Amomum melegueta. Zingerone has a greater effect on aflatoxin biosynthesis than on fungal growth. Kim et al. found that zingerone, at a concentration of 5 mM, reduced aflatoxin production to 11% of the control with little reduction in fungal growth. They also found that yeast mutants with increased sensitivity to mitochondrial oxidative stress were more susceptible to combined H2O2 and zingerone treatment than a wild‐type strain [92]. This result indicates that the antiaflatoxigenic activity of zingerone may be attributed to its alteration of the mitochondrial function in aflatoxin‐producing fungi. Flavonoids and isoflavonoids are also inhibitory to aflatoxin production, but most are active only at high concentrations. In an early study, flavonoids (eriodictyol and luteolin) isolated from peanut shells were tested for their effects on aflatoxin production by A. flavus and A. parasiticus. Eriodictyol showed considerable inhibition of aflatoxin production with minimal influence on fungal growth, while luteolin was much more potent against A. parasiticus (IC50< 0.35 mM) than against A. flavus(IC50∼6 mM). The authors suggested that the differences in the responses of A. flavus and A. parasiticus to luteolin may be caused either by differences between the two fungi or by the culture conditions [93]. In fact, A. flavus and A. parasiticus are known to respond differently to oxidative stress. It has been reported that some oxidizing agents such as cumene hydroperoxide stimulate aflatoxin biosynthesis in A. parasiticus but not in A. flavus [94]. Glyceollin is a soybean isoflavonoid that has promise for engineering aflatoxin resistance in plants. It has been reported that 20 μM glyceollin strongly inhibited aflatoxin production in a high‐glucose liquid medium, and the authors also speculated that glyceollin contributes to the resistance of soybean to aflatoxin contamination [95], although the mechanism by which glyceollin inhibits aflatoxin biosynthesis is uncertain. However, as a natural plant defense compound with a known biosynthetic pathway, glyceollin is particularly promising for the construction of aflatoxin resistant plants. Other biflavonoids have also been tested for their antiaflatoxigenic activity. Gonçalez et al. found that some of the major biflavonoids isolated from Ouratea species had excellent inhibitory activity at micromolar concentrations, reducing aflatoxin B1 production to <30% of the control at approximately 9 μM [96]. The antiaflatoxigenic effects of flavonoids and isoflavonoids might result from their antioxidant activity, because recent studies showed that aflatoxin production was closely related to the peroxidation of the fungal cell and several antioxidants have been reported to strongly inhibit aflatoxin production [97]. More recently, a study further underlined the importance of the role played by oxidative stress in the fungal cell in aflatoxin biosynthesis [98]. However, it has not been definitively demonstrated whether antioxidants work by direct interaction with reactive species or by the stimulation of the fungal cell antioxidant system. Furthermore, the molecular basis of the relationship between cell antioxidant defenses and aflatoxin formation is not yet fully understood. Information about the intracellular mechanism that leads to aflatoxin synthesis could be useful to achieve control over aflatoxin production. Piperine, a natural constituent found in many pepper species, inhibited aflatoxin production by A. parasiticus without obvious reduction in fungal growth. Piperine possesses direct antioxidant activity against various free radicals which may be related to its antiaflatoxigenic activity [99]. Phytic acid is an abundant component of seeds that can act as a chelator of polyvalent cations, especially zinc. The effect of phytic acid on aflatoxin production by A. parasiticus strongly depends on the pH of the medium: it was reported that 14.3 mM did not inhibit aflatoxin production at pH ≤ 4.5, but when the pH was about 6.6, phytic acid strongly inhibited aflatoxin production [100]. Regulation of aflatoxin production by phytic acid is attributed to its chelation of zinc and other polyvalent cations. It is also a natural antioxidant, and this antioxidant activity may also contribute to its antiaflatoxigenic properties by inhibiting iron‐catalyzed free radical production and lipid peroxidation [101].

Figure 1.

Schematic representation of aflatoxin production inhibition by natural products at different levels.

The second way to inhibit aflatoxin biosynthesis is to interfere with the signal transduction networks or gene expression regulation of aflatoxin biosynthesis by, for example, using calmodulin inhibitors, most of which are alkaloid and peptide compounds that have been isolated from a wide variety of natural sources, including many plant species [102]. Multiple lines of evidence support the idea that calcium‐dependent signaling plays an important role in the regulation of aflatoxin biosynthesis [103]. Calmodulin‐binding domains have been identified in the primary sequences of aflatoxin pathway transcriptional regulators (AflR and AflJ) and biosynthetic enzymes, presenting the possibility that calmodulin may influence transcriptional regulation of the aflatoxin biosynthesis gene cluster [104]. Aflastatin A and blasticidin A are well‐known microbial‐derived aflatoxin inhibitors. They are structurally related compounds produced by Streptomyces sp. that strongly inhibit aflatoxin production in A. parasiticus [57]. It has been reported that aflastatin A and blasticidin A inhibit the biosynthesis of important intermediates of aflatoxins (e.g., norsolorinic acid) and the transcription of aflatoxin biosynthetic genes [105]. Even though their mode of action is unknown, it was suggested that this inhibition is probably a result of perturbations in primary metabolism [106]. It has been reported that aflastatin A significantly enhances glucose utilization and the accumulation of ethanol in fungal cells. The level of transcription of genes for aldehyde dehydrogenase and acetyl‐CoA synthetase, which are involved in ethanol utilization, was also suppressed by aflastatin A [105]. Dioctatin A is another antibiotic isolated from Streptomyces sp. that inhibits both conidiation and aflatoxin biosynthesis in A. parasiticus. Dioctatin A treatment also reduced the expression of AflR and aflatoxin biosynthesis genes. The molecular target of dioctatin A has not yet been identified, although it was suggested that dioctatin A inhibits aflatoxin biosynthesis through the FadA heterotrimeric G‐protein signaling cascade [107]. Khellin and visnagin, products of the plant Ammi visnaga, were tested on A. flavus. Both showed potent inhibitory activity (IC50< 0.1 mM) for aflatoxin production [108]. Khellin and visnagin are pharmacological agents that can inhibit cyclic adenosine monophosphate (cAMP) phosphodiesterases inhibitory activity, and cAMP has been shown to influence aflatoxin production [109]. Hydroperoxy fatty acids from plants, including methyl jasmonate (MeJA), 9S‐hydroperoxy‐trans‐10,cis‐12‐octadecadienoic acid (9S‐HPODE), 13S‐hydroperoxy‐cis‐9,trans‐11‐octadecadienoic acid (13S‐HPODE), and 13S‐hydroperoxy‐cis‐9,trans‐11,cis‐15‐octadecatrienoic acid (13S‐HPOTE), can mimic fungal signal factors and could potentially interact with G‐protein‐coupled receptor complexes upstream of the heterotrimeric G‐protein complex that has been shown to regulate aflatoxin production [110]. Plant hydroperoxy fatty acids have varied effects on aflatoxin production. For example, MeJA significantly inhibited aflatoxin production by A. flavus on agar plates with an IC50< 10 nM, but stimulated aflatoxin production by A. parasiticus after 7‐day incubation in YES medium [111]. 13S‐HPODE and 13S‐HPOTE, at 100 μM, eliminated aflatoxin production by A. parasiticus in A&M medium, whereas 9S‐HPODE slightly increased or decreased aflatoxin production, depending on the concentration tested [111]. Burow and coworkers reported that, in in vitro experiments, 13S‐hydroperoxy fatty acids at concentrations of 10 and 100 μM repressed aflatoxin pathway gene expression and significantly reduced aflatoxin production in A. parasiticus. It has also been reported that treatment with 1 μM 13S‐hydroperoxy linoleic acid significantly decreased aflatoxin production when it was repeatedly added to growth media at 24‐h intervals. However, the same concentrations of 9S‐hydroperoxy linoleic acid did not reduce aflatoxin production. These results suggested that specific seed lipoxygenase activity could provide resistance to mycotoxin contamination by Aspergillus sp. [112].

The third way to inhibit aflatoxin biosynthesis is to block the activity of aflatoxin biosynthesis‐related enzymes. For example, coumarins have been found to strongly inhibit aflatoxin production without causing significant reductions in fungal growth [108]. It has been suggested that structural similarities between these coumarone and aflatoxins may result in competitive inhibition of biosynthetic enzymes. Terpenoids are a major class of natural products synthesized in plants through the mevalonic acid pathway. There are reports that different terpenoids, including camphene, α‐carotene, limonene, lutein, and zeaxanthin, are inhibitory to aflatoxin biosynthesis in solid or liquid media [113]. The inhibition by terpenoids may occur at the level of whole‐pathway regulation. For example, α‐carotene was found to be able to block the synthesis of norsolorinic acid, the first stable aflatoxin precursor, thereby preventing the accumulation of subsequent pathway intermediates. Caffeine is another well‐studied inhibitor of aflatoxin production, with studies showing that decaffeinated coffee beans and powder support higher aflatoxin production than normal beans and powder, and that incorporation of coffee into growth medium at concentrations of 1% (w/v) inhibits total aflatoxin production by 25%, with no significant reduction in fungal growth. The inhibitory effect of caffeine on glucose uptake is considered to be the possible mode of action for its antiaflatoxigenic activity [114]. Hydroxamic acids, such as 6‐methoxy‐benzoxazolin‐2‐one (MBOA), are also strong inhibitors of aflatoxin biosynthesis. MBOA significantly inhibits α‐amylase induction [115]. It was suggested that the perturbation of sugar utilization by MBOA might be the major reason for its antiaflatoxigenic activity.


4. Aflatoxin detoxification

Aflatoxins are extremely stable under most conditions encountered during food storage, handling, and processing. Therefore, preventing contamination with aflatoxigenic fungi is the most rational and economic approach for controlling aflatoxin contamination of food. However, detoxification of aflatoxin is required for food already contaminated with aflatoxin. Although various methods have been described for detoxification of aflatoxins in foods, the most commonly used physical and chemical approaches are usually high cost or complex processes, and many also result in nutrient loss and food safety issues.

Biological detoxification of aflatoxins by employing natural products has been shown to be very effective in removing aflatoxin from food. In principle, there are four possible biological approaches to avoid the toxic effects of aflatoxins on the human body: (1) remove aflatoxins through surface adsorption to bacterial or fungal cells; (2) transform aflatoxins into nontoxic compounds by enzymatic degradation; (3) introduce aflatoxin adsorbents into contaminated food and feed to bind the toxins and inhibit their absorption from the gastrointestinal tract; and (4) metabolize aflatoxin into relatively nontoxic compounds via different metabolic pathways (Figure 2).

Figure 2.

Schematic representation of aflatoxin reduction with different mode of action. 1 Detoxification in animal body; 2 Detoxification in human body.

Aflatoxin detoxifying microorganisms were first demonstrated in 1996, when Ciegler et al. identified a Flavobacterium aurantiacum strain. In their research, they also found that both growing and resting cells of F. aurantiacum could remove aflatoxin from contaminated milk, oil, peanut butter, peanuts, corn, and soybeans. The detoxification was found to be irreversible with no new toxic products being formed [116]. Lillehoj et al. found that while both living and dead cells of F. aurantiacum were capable of removing aflatoxin from solution, aflatoxins removed by living cells could not be recovered while toxins removed by dead cells were simply adsorbed to the cell walls [117]. Line and Brackett also found that the degradation of aflatoxin B1 by F. aurantiacum was independent of the nutrients in the culture medium, suggesting that this organism can be used for detoxification in different fermentation processes [118].

Over the last few decades, considerable literature has accumulated that describes methods for removing aflatoxins using different microorganisms. Pure cultures of bacteria and fungi that detoxify aflatoxins, which include Rhizopus sp., Aspergillus sp., Candida sp., Corynebacterium sp., Trichoderma sp., Mucor sp., Neurospora sp., and Rhodococcus sp., have been isolated from complex microbial populations by screening and enrichment culture techniques [119, 120]. Among these, Rhizopus sp. was reported to be specifically suitable for large‐scale detoxification of food and feed by solid‐state fermentation. However, when used in food, viable microorganisms must be controlled to avoid undesired fermentation and undesirable compounds [121]. Among the different potentially decontaminating microorganisms, yeasts and lactic acid bacteria (LAB) have been widely used as starter cultures in the food and beverage industry for thousands of years. Therefore, yeasts and LAB have enormous potential as tools for tackling the problem of aflatoxin contamination of foods and feed [122].

Many reports state that the use of brewer’s yeast cells as an animal feed additive resulted in a reduction in the toxic effects of aflatoxins [123]. In an early study, some yeast strains isolated from West African maize were found to be able to bind 15–60% (w/w) of aflatoxin B1 and this toxin binding was highly strain specific [124]. Yeast cells of Saccharomyces cerevisiae, which are generally used as performance promoters in poultry feeds, have also been shown to have beneficial effects against aflatoxin B1 exposure [125]. In fact, there have been many reports of yeasts and yeast cell components providing in varying degrees of protection of animals from aflatoxins in feed [126]. Baptista et al. reported that the addition of dried yeast and yeast cell walls to rat rations along with aflatoxin B1 resulted in a significant reduction of aflatoxin toxicity [127]. An in vitro study showed that modified mannan‐oligosaccharides derived from S. cerevisiae showed a dose‐dependent binding of aflatoxin as high as 95% (w/w) [128]. A later study confirmed that glucomannans from yeast cells have protective effects against the toxicity of aflatoxins in broiler chickens [129]. However, Baptista et al. found in a feeding experiment that mannan‐oligosaccharides did not show significant suppressive effects on aflatoxin‐induced damage in rats [127]. Unfortunately, no explanation could be given for this difference. It is well known that yeast cells bind sterols from the medium via cell wall mannan [130]. According to some of the studies reported, dead yeast cells still have this binding ability [127]. Therefore, it is likely that the removal of aflatoxin is not by covalent binding or metabolism, but by means of adhesion to cell wall components. It has been reported that the mannan components of the cell wall play a major role in aflatoxin binding by S. cerevisiae [128]. However, more kinetic studies are needed to assess the role of different components of the cell wall in aflatoxin binding.

The use of LAB in food fermentation dates back several centuries. Early studies showed that different LABs, including Lactobacillus rhamnosus, L. acidophilus, L. gasseri, and L. casei Shirota, could effectively remove up to 80% of aflatoxin B1 from contaminated culture media [131]. Among these, L. rhamnosus strains GG and LC705 showed similar aflatoxin B1 binding, even though they showed differences with respect to other metabolites. Later, more strains of LAB were found to be capable of binding aflatoxins in a strain‐specific manner [132]. Several studies also indicated that the aflatoxin binding ability of LAB is highly strain specific [133]. Haskard et al. studied the mechanism of aflatoxin binding to L. rhamnosus using enzyme treatments and showed that the binding is predominantly to carbohydrate and some protein components of the cell wall [134]. Urea treatment decreased the binding significantly, indicating that hydrophobic interactions play an important role. Recent studies have shown that peptidoglycan is most likely the carbohydrate involved in the aflatoxin B1 binding process [135]. Haskard et al. found that the binding of aflatoxins to the cell surface of L. rhamnosus strains LGG and LC105 is considerably strong [136]. Living cell retained 38 and 50% (w/w) of bound aflatoxin after repeated washings with water. Even stronger binding was found in heat‐ and acid‐treated cells which retained 66–71% (w/w) of the toxin, indicating a higher stability binding complex. This stronger binding was attributed to better access of aflatoxins to the treated cells. In addition, it has also been noted that autoclaving and sonication did not release any detectable toxin from prewashed cells, indicating the high stability of the complex. Binding of aflatoxins was also found to be unaffected by pH but could be easily disrupted with organic solvents, suggesting that hydrophobic interactions rather than cation exchange are the major mechanism of binding [134].

Enzymatic inactivation of aflatoxins is another attractive strategy for food decontamination. Several microorganisms can transform aflatoxin B1 to aflatoxicol and other less toxic or nontoxic compounds. It has been reported that aflatoxin B1 can be detoxified into aflatoxin B2a during yoghurt fermentation [137]; that aflatoxin B1 is detoxified during fermentation of milk by lactic bacteria [138]; and that Armillariella tabescens produces detoxification enzymes that show AFB1 detoxification activity [139]. A crude enzyme preparation isolated from Stenotrophomonas also showed strong aflatoxin‐degrading activity and could degrade 85.7% of aflatoxin B1 [140]. Several other microbes, including Corynebacterium rubrum, Aspergillus repens, Trichoderma viride, Mucor griseocyanus, Dactylium denroides, Mucor alternans, Rhizopus arrhizus, Rhizopus oryzae, and Rhizopus stolonifer, have been reported to possess aflatoxin‐degrading enzymes [141]. However, the degradation of aflatoxins is generally slow and incomplete: it was reported that D. dendroides, A. repens, and M. griseocyanus take 3–4 days to transform 60% of aflatoxin B1 to aflatoxicol [142].

Mycotoxin‐producing fungi are also able to degrade or transform aflatoxins and possibly use them as a source of energy under suitable conditions. Several investigators have observed that aflatoxigenic strains produce large amounts of aflatoxins that usually decrease during continued incubation of the cultures [143]. A. parasiticus and A. flavus have been demonstrated to be able to degrade aflatoxins in a process that is strongly affected by the mycelia and culture conditions (pH, temperature, and inoculum, etc.), and probably involves peroxidases and P450 monooxygenases [144]. Detoxification of aflatoxin B1 by a cell‐free enzyme preparation from Armillariella tabescens, an edible fungus used in Chinese traditional medicine, has also been reported [139]. Ames tests revealed a complete loss of mutagenicity and infrared spectroscopy of the product purified by thin‐layer chromatography indicated that the difuran ring skeleton had opened; however, the structure of the product remains to be determined.

Another practical approach to reducing the toxicity of aflatoxin to humans and animals is the addition of non‐nutritional inert adsorbents to the diet. These adsorbents sequester the aflatoxins in the gastrointestinal tract, thereby minimizing their toxic effects. Various adsorbents have been tested, including activated carbon, bentonite, cholestyramine, hydrated sodium calcium aluminosilicate, and zeolite, and produced promising results with respect to aflatoxin binding [145]. However, their application in food is limited because of their negative impacts such as reducing nutrient utilization. Therefore, the use of microorganisms and other natural products has become increasingly attractive as a reliable alternative to chemical adsorbents in the gastrointestinal tract.

The potential application of natural products as aflatoxin binders in human foods and animal feeds depends on their stability and the residence time of the complex in the gastrointestinal tract. The adhesion of aflatoxin‐binding microorganisms to intestinal cells appears to be highly strain specific. Yeast cells generally show very low adhesion to the intestine but are capable of withstanding the harsh environment of the gastrointestinal tract [146]. Animal feeding experiments have shown that the addition of whole cells or cell walls of S. cerevisiae to the diet resulted in a significant reduction of aflatoxin toxicity, indicating the possible stability of the yeast‐‐aflatoxin complex during its passage through the gastrointestinal tract [125]. A recent study in mice showed that S. cerevisiae over a 6‐week period improved weight gain and reduced the genotoxicity produced by aflatoxin B1 [147]. Yeast cell wall components have also been evaluated as aflatoxin adsorbents. An in vitro study showed that esterified glucomannan from yeast cells displayed a very high capacity (97%) to adsorb aflatoxin B1 from aqueous solutions [148]. The addition of esterified glucomannan (0.1%) to chicken feed containing aflatoxins (2 mg/kg) significantly reduced the potentially adverse effects of the aflatoxins on hematological parameters, total protein, albumin values, and aspartate amino‐transferase activity in broiler chickens. Other in vivo studies also showed that esterified glucomannan decreased the number and severity of pathological changes caused by aflatoxin treatment [129].

LAB cells usually show considerably higher adhesion to intestinal cells compared with that of yeast cells. However, it has been reported that aflatoxin binding considerably reduced the adhesive properties of some LAB strains and resulted in the faster excretion of immobilized aflatoxin B1 [149]. Gratz et al. also found that pre‐exposure of the cells of a L. rhamnosus strain to aflatoxin B1 reduced its binding to intestinal mucus and thus resulted in the faster removal of bound aflatoxin [150]. An in vitro study using the chicken duodenum loop technique showed that a L. rhamnosus strain removed up to 54% (w/w) of the added aflatoxin B1 and reduced as much as 73% of intestinal adsorption [151]. Some researchers have suggested that the aflatoxin molecules bind to bacterial cell wall components such as polysaccharide and peptidoglycan [152]. Bacterial cell surface hydrophobicity may also play an important role in the binding of aflatoxins.

Aflatoxins absorbed into the bodies of humans or animals may also be metabolized into relatively nontoxic compounds via different metabolic pathways. The process of detoxification of aflatoxins usually involves removing the double bond of the terminal furan ring or opening the lactone ring. Once the lactone ring is opened, further reactions can occur to alter their binding properties to DNA and proteins [153]. The main reactions of aflatoxin metabolism in humans and animals are hydroxylation, oxidation, and demethylation. There are numerous studies concerning the metabolism of aflatoxin in vitro and in vivo. Salhab and Edwards found that the liver preparations of rabbit and trout were able to metabolize aflatoxin B1 into aflatoxicol by reducing the cyclopentenone carbonyl of aflatoxin B1 in an in vitro experiment [154]. An in vivo study by Roebuck and Wogan also found that aflatoxicol is the major metabolite of aflatoxin B1 in duck liver, whereas aflatoxin B1 was mainly converted into aflatoxin P1 and aflatoxin Q1 (relatively nontoxic) in human and monkey livers [155]. In fact, there is a great diversity among different animal species in the metabolism of aflatoxins. For example, aflatoxin B1 was able to convert into aflatoxin M1 in ducks, rats, and monkeys but not in humans [156], while in chicken liver, aflatoxin B1 was metabolized into a peptide conjugate of aflatoxin B2a and a glucuronide conjugate of aflatoxin M1 [157]. Donnelly et al. found that lipoxygenase and prostaglandin H synthase were the main enzymes responsible for the biotransformation of aflatoxin B1 in human lung, while in rat liver, aflatoxin B1 is transformed by a mixed‐function monooxygenase [158]. In addition, various forms of cytochromes were found to have different biotransformation capacities for aflatoxins. Yoshizawa et al. reported that, in rat liver, transformation of aflatoxin M1 was strictly mediated by cytochrome P448, while transformation of aflatoxin Q1 was catalyzed by both cytochrome P450 and P448 [159]. In human liver, the cytochrome P450‐dependent polysubstrate monooxygenase system is the major isoform involved in aflatoxin transformation [158].


5. Application of natural inhibitors

The preferred strategy for reducing the concentrations of aflatoxins in foods is prevention of aflatoxin formation during preharvest and postharvest of the various susceptible crops. In this context, non‐aflatoxigenic Aspergillus strains have been used to prevent preharvest aflatoxin contamination of crops, such as peanuts, maize, and cottonseed, and have shown great potential. Recent advancements in the use of biocontrol strategies involving microorganisms should soon lead to increased practical applications for the benefit of the food industry. Some microorganisms such as R. stolonifer and A. fumigatus, which have been used in aflatoxin removal experiments, are not likely to be used in the field because of their potential to cause infection of the plants. However, these strains could still be used to provide natural compounds for prevention of aflatoxin formation. Alternatively, the genes responsible for their antiaflatoxigenic activity could possibly be incorporated into the host plant genome to produce crops resistant to aflatoxin contamination. The use of metabolites from microorganisms and plants as natural agents to control aflatoxin contamination has received much attention in recent years. Although the use of natural metabolites has shown promising results under controlled conditions in in vitro experiments, these studies need to be extended in situ to systems involving foods or feeds. More work is required to further characterize the antifungal and antiaflatoxigenic mechanisms involved.

To achieve effective control of aflatoxin contamination in food, high concentrations of natural compounds are generally needed. The incorporation of natural compounds into packaging materials can be a useful strategy to solve this problem. In the last decade, there have been plentiful studies of the development of active packaging materials. Because the introduction of protective agents in packaging materials can be used to protect food without direct addition of new chemicals, it has received great interest from both the food industry and academic communities. Many natural extracts, such as essential oils and their constituents, are categorized as flavorings in Europe and are categorized as Generally Recognized as Safe (GRAS) by the U.S. Food and Drug Administration. For this reason, they have often been proposed for and used in active packaging. For the purpose of the design of active packaging, it is necessary to establish which compounds have antiaflatoxigenic properties and what concentration is required to obtain maximum inhibition. In addition, because the volatile nature of some components, the release rate of the encapsulated compounds from their polymer matrix should be controlled, thereby magnifying their antiaflatoxigenic action on the product by both direct contact and through the head space of the packaging. The processes of encapsulating natural aflatoxin inhibitors into the polymer matrix should also be carefully controlled. Previous studies have shown notable losses of the active compounds during the film formation step of the casting technique [160].

Nanotechnology‐based systems associated with natural compounds are also a good option. There are many well‐known benefits of associating natural compounds with nanotechnological drug‐delivery systems [161]. One good example is a nanoemulsion: in an emulsified form, natural compounds may be applied as an aqueous‐based treatment. In fact, fine droplets may improve the delivery of inhibitory compounds to cereals because they may be able to penetrate into the cracks and crevices on the cereal surfaces. Nanoemulsions are emulsion droplets with a radius below 100 nm, which can be formed using both high‐energy and low‐energy methods [162]. High‐energy methods require specialized mechanical devices, such as high pressure valve homogenizers, sonicators and microfluidizers. These devices are capable of generating intense mechanical forces that can intermingle and disrupt the oil and water phases. Low‐energy methods rely on the spontaneous formation of nano‐sized oil droplets, which is a physicochemical process that occurs under appropriate conditions with certain combinations of surfactant, oil, and water. The spontaneous emulsification method has recently been reported to be suitable for application in the food industry for fabricating effective antimicrobial nanoemulsions from essential oils [163].

As mentioned previously, genetic engineering is another way to utilize these compounds. Host crop species can be engineered to gain resistance to aflatoxin contamination by incorporation of the genes for biosynthesis of natural inhibitors. There are likely hundreds, if not thousands, of natural compounds that influence aflatoxin biosynthesis at concentrations ranging from submicromolar to millimolar. Unfortunately, many of these inhibitors are not suitable for genetic engineering. The complexity of altering plant natural product pathways makes it difficult to engineer crop species resistant to aflatoxin contamination. In addition, the majority of aflatoxin inhibitors reported so far were tested in vitro in media that do not approximate the conditions on the host plant. The tissue specificity and/or inducible expression of inhibitors are also important considerations [164]. Therefore, it is critical to identify the most promising candidates before attempting to engineer aflatoxin‐resistant plants. Compared with the production of exogenous inhibitors, the development of plants that already possess aflatoxin inhibitors might be easier, because the biosynthetic pathways are already present in the host, and an increased inhibitor concentration can be achieved by upregulating endogenous genes. Most genetic and molecular approaches aimed at preventing aflatoxin biosynthesis have not yet reached commercial application in the field and require substantial further development.


6. Conclusions

In summary, there are various natural compounds that influence aflatoxin contamination in food through different ways, including inhibition of the growth of aflatoxigenic fungi, blocking aflatoxin biosynthesis, and removal or degradation of aflatoxin. These inhibitors are highly promising for the development of new approaches to fighting aflatoxin contamination in food and have the capability to replace or complement conventional strategies. A common feature of many inhibitors is their antioxidant activity; yet, the relationship of antiaflatoxigenic activity and antioxidant activity is unknown. Some inhibitors of aflatoxin production are specifically targeted to the biosynthesis of aflatoxin without affecting the development of the fungal cells. However, most inhibitors also inhibit fungal growth at higher concentrations. This may indicate that secondary metabolism (aflatoxin) is sensitive to stress resulting from low concentrations of growth‐inhibitory compounds. The production of norsolorinic acid, the first stable intermediate in the aflatoxin biosynthetic pathway, was inhibited in parallel with aflatoxin production at the regulatory level of biosynthesis rather than at specific steps within the pathway, indicating the importance of this intermediate. More and more natural inhibitors are being identified, yet the modes of action of most are poorly understood. Further studies are necessary to better understand the mechanisms of action of those compounds before they can be widely used commercially. Using new biological approaches, researchers are now combining datasets from profiling of transcripts, proteins, and metabolites generated using inhibitory compounds with different modes of action, which will provide useful information for dissecting different facets of aflatoxin regulation.


  1. 1. Gourama H, Bullerman LB. Aspergillus flavus and Aspergillus parasiticus: Aflatoxigenic fungi of concern in foods and feeds: A review. Journal of Food Protection. 1995;58(12):1395-1404.
  2. 2. Klich MA. Soil fungi of some low‐altitude desert cotton fields and ability of their extracts to inhibit Aspergillus flavus. Mycopathologia. 1998;142:97-100.
  3. 3. Bennett JW, Leong PM, Kruger S, Keyes D. Sclerotial and low aflatoxigenic morphological variants from haploid and diploid Aspergillus parasiticus. Cellular and Molecular Life Sciences. 1986;42(7):848-851.
  4. 4. Perrone G, Susca A, Cozzi G, Ehrlich K, Varga J, Frisvad JC, Samson RA. Biodiversity of Aspergillus species in some important agricultural products. Studies in Mycology. 2007;59:53-66.
  5. 5. Robens J, Cardwell K. The costs of mycotoxin management to the USA: Management of aflatoxins in the United States. Journal of Toxicology: Toxin Reviews. 2003;22(2-3):139-152.
  6. 6. Allcroft R, Carnaghan RBA, Sargeant K, O’kelly J. A toxic factor in Brazilian groundnut meal. Veterinary Record. 1961;73:428-429.
  7. 7. Van Egmond HP. Current situation on regulations for mycotoxins. Overview of tolerances and status of standard methods of sampling and analysis. Food Additives & Contaminants. 1989;6(2):139-188.
  8. 8. Wogan GN. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Research. 1992;52(7 Supplement):2114s–2118s.
  9. 9. Van Egmond HP, Schothorst RC, Jonker MA. Regulations relating to mycotoxins in food. Analytical and Bioanalytical Chemistry. 2007;389(1):147-157.
  10. 10. Bata Á, Lásztity R. Detoxification of mycotoxin‐contaminated food and feed by microorganisms. Trends in Food Science & Technology. 1999;10(6):223-228.
  11. 11. Piva G, Galvano F, Pietri A, Piva A. Detoxification methods of aflatoxins. A review. Nutrition Research. 1995;15(5):767-776.
  12. 12. Line JE, Brackett RE. Factors affecting aflatoxin B1 removal by Flavobacterium aurantiacum. Journal of Food Protection. 1995;58(1):91-94.
  13. 13. Pal KK, Gardener BM. Biological control of plant pathogens. The Plant Health Instructor. 2006;2:1117-1142.
  14. 14. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clinical Microbiology Reviews. 1998;11(2):382-402.
  15. 15. Klich MA. Environmental and developmental factors influencing aflatoxin production by Aspergillus flavus and Aspergillus parasiticus. Mycoscience. 2007;48(2):71-80.
  16. 16. Rana BK, Singh UP, Taneja V. Antifungal activity and kinetics of inhibition by essential oil isolated from leaves of Aegle marmelos. Journal of Ethnopharmacology. 1997;57(1):29-34.
  17. 17. Hamilton‐Kemp TR, McCracken CT, Loughrin JH, Andersen RA, Hildebrand DF. Effects of some natural volatile compounds on the pathogenic fungi Alternaria alternata and Botrytis cinerea. Journal of Chemical Ecology. 1992;18(7):1083-1091.
  18. 18. Caccioni DR, Guizzardi M. Inhibition of germination and growth of fruit and vegetable postharvest pathogenic fungi by essential oil components. Journal of Essential Oil Research. 1994;6(2):173-179.
  19. 19. Wilson CL, Franklin JD, Otto BE. Fruit volatiles inhibitory to Monilinia fructicola and Botrytis cinerea. Plant Disease. 1987;71(4):316-319.
  20. 20. El Ghaouth A, Arul J, Grenier J, Asselin A. Antifungal activity of chitosan on two postharvest pathogens of strawberry fruits. Phytopathology. 1992;82(4):398-402.
  21. 21. Altomare C, Perrone G, Stornelli C, Bottalico A. Quaderni della Scuola di specializzazione in Viticoltura ed Enologia. University of Torino, Italy. 1998;22:59-66.
  22. 22. Chitarra GS, Abee T, Rombouts FM, Posthumus MA, Dijksterhuis J. Germination of Penicillium paneum conidia is regulated by 1‐octen‐3‐ol, a volatile self‐inhibitor. Applied and Environmental Microbiology. 2004;70(5):2823-2829.
  23. 23. Rosengaus RB, Lefebvre ML,Traniello JF. Inhibition of fungal spore germination by Nasutitermes: evidence for a possible antiseptic role of soldier defensive secretions. Journal of Chemical Ecology. 2000;26(1):21-39.
  24. 24. Cole L, Davies D, Hyde GJ, Ashford AE. Brefeldin A affects growth, endoplasmic reticulum, golgi bodies, tubular vacuole system, and secretory pathway in Pisolithus tinctorius. Fungal Genetics and Biology. 2000;29(2):95-106.
  25. 25. Ahmad A, Khan A, Akhtar F, Yousuf S, Xess I, Khan LA, Manzoor N. Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. European Journal of Clinical Microbiology & Infectious Diseases. 2011;30(1):41-50.
  26. 26. Pinto E, Vale‐Silva L, Cavaleiro C, Salgueiro L. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. Journal of Medical Microbiology. 2009;58(11):1454-1462.
  27. 27. Thevissen K, Terras FR, Broekaert WF. Permeabilization of fungal membranes by plant defensins inhibits fungal growth. Applied and Environmental Microbiology. 1999;65(12): 5451-5545.
  28. 28. Ahmad A, Khan A, Manzoor N, Khan LA. Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microbial Pathogenesis. 2010;48(1):35-41.
  29. 29. Bard M, Albrecht MR, Gupta N, Guynn CJ, Stillwell W. Geraniol interferes with membrane functions in strains of Candida and Saccharomyces. Lipids. 1988;23(6):534-538.
  30. 30. Khan A, Ahmad A, Akhtar F, Yousuf S, Xess I, Khan LA, Manzoor N. Ocimum sanctum essential oil and its active principles exert their antifungal activity by disrupting ergosterol biosynthesis and membrane integrity. Research in Microbiology. 2010;161(10):816-823.
  31. 31. Abad LR, D’Urzo MP, Liu D, Narasimhan ML, Reuveni M, Zhu JK, Niu X, Singh NK, Hasegawa PM, Bressan RA. Antifungal activity of tobacco osmotin has specificity and involves plasma membrane permeabilization. Plant Science. 1996;118(1):11-23.
  32. 32. de Lira Mota KS, de Oliveira Pereira F, de Oliveira WA, Lima IO, de Oliveira Lima E. Antifungal activity of Thymus vulgaris L. essential oil and its constituent phytochemicals against Rhizopus oryzae: interaction with ergosterol. Molecules. 2012;17(12):14418-14433.
  33. 33. Roberts WK, Selitrennikoff CP. Zeamatin, an antifungal protein from maize with membrane‐permeabilizing activity. Microbiology. 1990;136(9):1771-1778.
  34. 34. Kunze B, Steinmetz H, Höfle G, Huss M, Wieczorek H, Reichenbach H. Cruentaren, a new antifungal salicylate‐type macrolide from Byssovorax cruenta (Myxobacteria) with inhibitory effect on mitochondrial ATPase activity. Journal of Antibiotics. 2006;59(10):664.
  35. 35. Aerts AM, Bammens L, Govaert G, Carmona‐Gutierrez D, Madeo F, Cammue B, Thevissen K. The antifungal plant defensin HsAFP1 from Heuchera sanguinea induces apoptosis in Candida albicans. Frontiers in Microbiology. 2011;2:47.
  36. 36. Tian J, Ban X, Zeng H, He J, Chen Y, Wang Y. The mechanism of antifungal action of essential oil from dill (Anethum graveolens L.) on Aspergillus flavus. PLoS One. 2012;7(1):e30147.
  37. 37. Fudou R, Iizuka T, Yamanaka S. Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium. 1. Fermentation and biological characteristics. The Journal of Antibiotics. 2001;54(2):149-152.
  38. 38. Jeandet P, Douillet‐Breuil AC, Bessis R, Debord S, Sbaghi M, Adrian M. Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. Journal of Agricultural and Food Chemistry. 2002;50(10):2731-2741.
  39. 39. Wu XZ, Cheng AX, Sun LM, Sun SJ, Lou HX. Plagiochin E, an antifungal bis (bibenzyl), exerts its antifungal activity through mitochondrial dysfunction‐induced reactive oxygen species accumulation in Candida albicans. Biochimica et Biophysica Acta (BBA)‐General Subjects. 2009;1790(8):770-777.
  40. 40. El‐Banna N, Winkelmann G. Pyrrolnitrin from Burkholderia cepacia: antibiotic activity against fungi and novel activities against streptomycetes. Journal of Applied Microbiology. 1998;85(1):69-78.
  41. 41. Romagnoli C, Bruni R, Andreotti E, Rai MK, Vicentini CB, Mares D. Chemical characterization and antifungal activity of essential oil of capitula from wild Indian Tagetes patula L. Protoplasma. 2005;225(1-2):57-65.
  42. 42. Ueki M, Taniguchi M. The mode of action of UK‐2A and UK‐3A, novel antifungal antibiotics from Streptomyces sp. 517‐02. The Journal of Antibiotics. 1997;50(12):1052-1057.
  43. 43. Khan A, Rahman M, Islam MS. Antibacterial, antifungal and cytotoxic activities of amblyone isolated from Amorphophallus campanulatus. Indian Journal of Pharmacology. 2008;40(1):41.
  44. 44. Moyne AL, Shelby R, Cleveland TE, Tuzun S. Bacillomycin D: an iturin with antifungal activity against Aspergillus flavus. Journal of Applied Microbiology. 2001;90(4):622-629.
  45. 45. Munimbazi C, Bullerman LB. Inhibition of aflatoxin production of Aspergillus parasiticus NRRL 2999 by Bacillus pumilus. Mycopathologia. 1997;140(3):163-169.
  46. 46. Cho SJ, Lee SK, Cha BJ, Kim YH, Shin KS. Detection and characterization of the Gloeosporium gloeosporioides growth inhibitory compound iturin A from Bacillus subtilis strain KS03. FEMS Microbiology Letters. 2003;223(1):47-51.
  47. 47. Chitarra GS, Breeuwer P, Nout MJR, Van Aelst AC, Rombouts FM, Abee T. An antifungal compound produced by Bacillus subtilis YM 10-20 inhibits germination of Penicillium roqueforti conidiospores. Journal of Applied Microbiology. 2003;94(2):159-166.
  48. 48. Wicklow DT, Joshi BK, Gamble WR, Gloer JB, Dowd PF. Antifungal metabolites (monorden, monocillin IV, and cerebrosides) from Humicola fuscoatra Traaen NRRL 22980, a mycoparasite of Aspergillus flavus sclerotia. Applied and Environmental Microbiology. 1998;64(11):4482-4484.
  49. 49. Gourama H, Bullerman LB. Antimycotic and antiaflatoxigenic effect of lactic acid bacteria: a review. Journal of Food Protection. 1995;58(11):1275-1280.
  50. 50. Coallier‐Ascah J, Idziak ES. Interaction between Streptococcus lactis and Aspergillus flavus on production of aflatoxin. Applied and Environmental Microbiology. 1985;49(1): 163-167.
  51. 51. Gourama H, Bullerman LB. Inhibition of growth and aflatoxin production of Aspergillus flavus by Lactobacillus species. Journal of Food Protection. 1995;58(11):1249-1256.
  52. 52. Gourama H, Bullerman LB. Anti‐aflatoxigenic activity of Lactobacillus casei pseudoplantarum. International Journal of Food Microbiology. 1997;34(2):131-143.
  53. 53. Batish VK, Grover S, Lal R. Screening lactic starter cultures for antifungal activity. Cultured Dairy Products Journal. 1989;24:23-25.
  54. 54. Roy U, Batish VK, Grover S, Neelakantan S. Production of antifungal substance by Lactococcus lactis subsp. lactis CHD‐28.3. International Journal of Food Microbiology. 1996;32(1-2):27-34.
  55. 55. Wanga SL, Yieh TC, Shih L. Purification and characterization of a new antifungal compound produced by Pseudomonas aeruginosa K‐187 in a shrimp and crab shell powder medium. Enzyme and Microbial Technology. 1999;25(3):439-446.
  56. 56. Dhanasekaran D, Thajuddin N, Panneerselvam A. An antifungal compound: 4′ phenyl‐1‐napthyl–phenyl acetamide from Streptomyces sp. DPTB16. Facta Universitatis Ser Med Biol. 2008;15:7-12.
  57. 57. Ono M, Sakuda S, Suzuki A, Isogai A. Aflastatin A, a novel inhibitor of aflatoxin production by aflatoxigenic fungi. The Journal of Antibiotics. 1997;50(2):111-118.
  58. 58. Narayana KJ, Prabhakar P, Vijayalakshmi MUVVA, Venkateswarlu Y, Krishna PS. Study on bioactive compounds from Streptomyces sp. ANU 6277. Polish Journal of Microbiol-ogy. 2008;57(1):35.
  59. 59. Ross RP, Morgan S, Hill C. Preservation and fermentation: past, present and future. International Journal of Food Microbiology. 2002;79(1):3-16.
  60. 60. Lavermicocca P, Valerio F, Visconti A. Antifungal activity of phenyllactic acid against molds isolated from bakery products. Applied and Environmental Microbiology. 2003;69(1):634-640.
  61. 61. Rizzello C, Cassone A, Coda R, Gobbetti M. Antifungal activity of sourdough ferment-ed wheat germ used as an ingredient for bread making. Food Chemistry. 2011;127(3):952-959.
  62. 62. Ryan LA, Zannini E, Dal Bello F, Pawlowska A, Koehler P, Arendt EK. Lactobacillus amylovorus DSM 19280 as a novel food‐grade antifungal agent for bakery products. International Journal of Food Microbiology. 2011;146(3):276-283.
  63. 63. Axelsson LT, Chung TC, Dobrogosz WJ, Lindgren SE. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microbial Ecology in Health and Disease. 1989;2(2):131-136.
  64. 64. Ndagano D, Lamoureux T, Dortu C, Vandermoten S, Thonart P. Antifungal activity of 2 lactic acid bacteria of the Weissella genus isolated from food. Journal of Food Science. 2011;76(6):305-311.
  65. 65. Garofalo C, Zannini E, Aquilanti L, Silvestri G, Fierro O, Picariello G, Clementi F. Selection of sourdough lactobacilli with antifungal activity for use as biopreservatives in bakery products. Journal of Agricultural and Food Chemistry. 2012;60(31):7719-7728.
  66. 66. Reddy KRN, Reddy CS, Muralidharan K. Potential of botanicals and biocontrol agents on growth and aflatoxin production by Aspergillus flavus infecting rice grains. Food Control. 2009;20(2):173-178.
  67. 67. Nakaya K, Omata K, Okahashi I, Nakamura Y, Kolkenbrock H, Ulbrich N. Amino acid sequence and disulfide bridges of an antifungal protein isolated from Aspergillus giganteus. The FEBS Journal. 1990;193(1):31-38.
  68. 68. García-Olmedo F, Molina A, Alamillo JM, Rodríguez-Palenzuéla P. Plant defense peptides. Peptide Science. 1998;47(6):479-491.
  69. 69. Lee DG, Shin SY, Maeng CY, Jin ZZ, Kim KL, Hahm KS. Isolation and characterization of a novel antifungal peptide from Aspergillus niger. Biochemical and Biophysical Research Communications. 1999;263(3):646-651.
  70. 70. Bhatnagar D. The inhibitory effect of neem (Azadirachta indica) leaf extracts on aflatoxin synthesis in Aspergillus parasiticus. Journal of the American Oil Chemists’ Society. 1988;65(7):1166-1168.
  71. 71. Bhargava KS, Dixit SN, Dubey NK, Tripathi RD. Fungitoxic properties of Ocimum canum. Journal of Indian Botanical Society. 1981;60:24-27.
  72. 72. Huang Z, White DG, Payne GA. Corn seed proteins inhibitory to Aspergillus flavus and aflatoxin biosynthesis. Phytopathology. 1997;87(6):622-627.
  73. 73. Chen ZY, Brown RL, Russin JS, Lax AR, Cleveland TE. A corn trypsin inhibitor with antifungal activity inhibits Aspergillus flavus α‐amylase. Phytopathology. 1999;89(10):902-907.
  74. 74. Gooday GW. Biosynthesis of the fungal wall‐mechanisms and implications the first Fleming Lecture. Microbiology. 1977;99(1):1-11.
  75. 75. Bell AA. Biochemical mechanisms of disease resistance. Annual Reviews of Plant Physiol-ogy. 1981;32:21-81.
  76. 76. Roberts WK, Selitrennikoff CP. Isolation and partial characterization of two antifungal proteins from barley. Biochimica et Biophysica Acta (BBA)‐General Subjects. 1986;880(2-3):161-170.
  77. 77. Boller T, Gehri A, Mauch F, Vögeli U. Chitinase in bean leaves: induction by ethylene, purification, properties, and possible function. Planta. 1983;157(1):22-31.
  78. 78. Mauch F, Mauch‐Mani B, Boller T. Antifungal hydrolases in pea tissue. 11. Inhibition of fungal growth by combinations of chitinase and p‐1,3‐glucanase. Plant Physiology. 1988;88(3):936-942.
  79. 79. Roberts WK, Selitrennikoff CP. Plant and bacterial chitinases differ in antifungal activity. Journal of General Microbiology. 1988;134(1):169-176.
  80. 80. Lockey TD, Ourth DD. Formation of pores in Escherichia coli cell membranes by a cecropin isolated from hemolymph of Heliothis virescens larvae. European Journal of Biochemistry. 1996;236(1):263-271.
  81. 81. Powell WA, Catranis CM, Maynard CA. Synthetic antimicrobial peptide design. MPMI‐Molecular Plant Microbe Interactions. 1995;8(5):792.
  82. 82. Holmes RA, Boston RS, Payne GA. Diverse inhibitors of aflatoxin biosynthesis. Applied Microbiology and Biotechnology. 2008;78(4):559-572.
  83. 83. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives (review). International Journal of medicinal mushrooms. 1999;1(1):31-62.
  84. 84. Slameňová D, Lábaj J, Kogan G, Šandula J, Bresgen N, Eckl P. Protective effects of fungal (1→ 3)‐β‐D‐glucan derivatives against oxidative DNA lesions in V79 hamster lung cells. Cancer Letters. 2003;198(2):153-160.
  85. 85. Yuan C, Mei Z, Shangxi L, Yi L. PSK protects macrophages from lipoperoxide accumulation and foam cell formation caused by oxidatively modified low‐density lipoprotein. Atherosclerosis. 1996;124(2):171-181.
  86. 86. Guo FC, Kwakkel RP, Williams BA, Li WK, Li HS, Luo JY, Li XP, Wei YX, Yan ZT, Verstegen MWA. Effects of mushroom and herb polysaccharides, as alternatives for an antibiotic, on growth performance of broilers. British Poultry Science. 2004;45(5):684-694.
  87. 87. Xu Y. Perspectives on the 21st century development of functional foods: bridging Chinese medicated diet and functional foods. International Journal of Food Science & Technology. 2001;36(3):229-242.
  88. 88. Jermnak U, Yoshinari T, Sugiyama Y, Tsuyuki R, Nagasawa H, Sakuda S. Isolation of methyl syringate as a specific aflatoxin production inhibitor from the essential oil of Betula alba and aflatoxin production inhibitory activities of its related compounds. International Journal of Food Microbiology. 2012;153(3):339-344.
  89. 89. Mahmoud AL. Antifungal action and antiaflatoxigenic properties of some essential oil constituents. Letters in Applied Microbiology. 1994;19(2):110-113.
  90. 90. Sidhu OP, Chandra H, Behl HM. Occurrence of aflatoxins in mahua (Madhuca indica Gmel.) seeds: Synergistic effect of plant extracts on inhibition of Aspergillus flavus growth and aflatoxin production. Food and Chemical Toxicology. 2009;47(4):774-777.
  91. 91. Jayashree T, Subramanyam C. Antiaflatoxigenic activity of eugenol is due to inhibition of lipid peroxidation. Letters in Applied Microbiology. 1999;28(3):179-183.
  92. 92. Kim JH, Campbell BC, Mahoney NE, Chan KL, Molyneux RJ. Identification of phenolics for control of Aspergillus flavus using Saccharomyces cerevisiae in a model target‐gene bioassay. Journal of Agricultural and Food Chemistry. 2004;52(26):7814-7821.
  93. 93. DeLucca AJ, Palmgren MS, Daigle DJ. Depression of aflatoxin production by flavonoid‐type compounds from peanut shells. Phytopathology. 1987;77(11):1560-1563.
  94. 94. De Luca C, Passi S, Fabbri AA, Fanelli C. Ergosterol oxidation may be considered a signal for fungal growth and aflatoxin production in Aspergillus parasiticus. Food Additives & Contaminants. 1995;12(3):445-450.
  95. 95. Song DK, Karr AL. Soybean phytoalexin, glyceollin, prevents accumulation of aflatoxin B 1 in cultures of Aspergillus flavus. Journal of Chemical Ecology. 1993;19(6):1183-1194.
  96. 96. Gonçalez E, Felicio JD, Pinto MM. Biflavonoids inhibit the production of aflatoxin by Aspergillus flavus. Brazilian Journal of Medical and Biological Research. 2001;34(11):1453-1456.
  97. 97. Paster N, Juven BJ, Harshemesh H. Antimicrobial activity and inhibition of aflatoxin B1 formation by olive plant tissue constituents. Journal of Applied Bacteriology. 1988;64(4):293-297.
  98. 98. Jayashree T, Subramanyam C. Oxidative stress as a prerequisite for aflatoxin production by Aspergillus parasiticus. Free Radical Biology and Medicine. 2000;29(10):981-985.
  99. 99. Lee SE, Mahoney NE, Campbell BC. Inhibition of aflatoxin B1 biosynthesis by piperlongumine isolated from Piper longum L. Journal of Microbiology and Biotechnology. 2002;12(4):679-682.
  100. 100. Ehrlich K, Ciegler A. Effect of phytate on aflatoxin formation by Aspergillus parasiticus and Aspergillus flavus in synthetic media. Mycopathologia. 1984;87(1-2):99-103.
  101. 101. Graf E, Empson KL, Eaton, JW. Phytic acid. A natural antioxidant. Journal of Biological Chemistry. 1987;262(24):11647-11650.
  102. 102. Martínez‐Luis S, Pérez‐Vásquez A, Mata R. Natural products with calmodulin inhibitor properties. Phytochemistry. 2007;68(14):1882-1903.
  103. 103. Praveen Rao, J, Subramanyam C. Calmodulin mediated activation of acetyl-CoA carboxylase during aflatoxin production by Aspergillus parasiticus. Letters in Applied Microbiology. 2000;30(4):277-281.
  104. 104. Juvvadi PR, Chivukula S. Putative calmodulin‐binding domains in aflatoxin biosynthesis–regulatory proteins. Current Microbiology. 2006;52(6):493-496.
  105. 105. Kondo T, Sakurada M, Okamoto S, Ono M, Tsukigi H, Suzuki A, Sakuda S. Effects of aflastatin A, an inhibitor of aflatoxin production, on aflatoxin biosynthetic pathway and glucose metabolism in Aspergillus parasiticus. The Journal of Antibiotics. 2001;54(8):650-657.
  106. 106. Yoshinari T, Akiyama T, Nakamura K, Kondo T, Takahashi Y, Muraoka Y, Nonomura Y, Nagasawa H, Sakuda, S. Dioctatin A is a strong inhibitor of aflatoxin production by Aspergillus parasiticus. Microbiology. 2007;153(8):2774-2780.
  107. 107. Yoshinari T, Noda Y, Yoda K, Sezaki H, Nagasawa H, Sakuda S. Inhibitory activity of blasticidin A, a strong aflatoxin production inhibitor, on protein synthesis of yeast: Selective inhibition of aflatoxin production by protein synthesis inhibitors. The Journal of Antibiotics. 2010;63(6):309-314.
  108. 108. Mabrouk SS, El‐Shayeb NMA. Inhibition of aflatoxin production in Aspergillus flavus by natural coumarone and chromones. World Journal of Microbiology and Biotechnology. 1992;8(1):60-62.
  109. 109. Roze LV, Beaudry RM, Keller NP, Linz JE. Regulation of aflatoxin synthesis by FadA/cAMP/protein kinase A signaling in Aspergillus parasiticus. Mycopathologia. 2004;158(2):219-232.
  110. 110. Brodhagen M, Keller NP. Signalling pathways connecting mycotoxin production and sporulation. Molecular Plant Pathology. 2006;7(4):285-301.
  111. 111. Vergopoulou S, Galanopoulou D, Markaki P. Methyl jasmonate stimulates aflatoxin B1 biosynthesis by Aspergillus parasiticus. Journal of Agricultural and Food Chemistry. 2001;49(7):3494-3498.
  112. 112. Burow GB, Nesbitt TC, Dunlap J, Keller NP. Seed lipoxygenase products modulate Aspergillus mycotoxin biosynthesis. Molecular Plant‐Microbe Interactions. 1997;10(3): 380-387.
  113. 113. Greene‐McDowelle DM, Ingber B, Wright MS, Zeringue HJ, Bhatnagar D, Cleveland TE. The effects of selected cotton‐leaf volatiles on growth, development and aflatoxin production of Aspergillus parasiticus. Toxicon. 1999;37(6):883-893.
  114. 114. Buchanan RL, Hoover DG, Jones SB. Caffeine inhibition of aflatoxin production: mode of action. Applied and Environmental Microbiology. 1983;46(5):1193-1200.
  115. 115. Kato‐Noguchi H, Macías FA. Possible mechanism of inhibition of 6‐methoxy‐benzoxazolin‐2 (3H)‐one on germination of cress (Lepidium sativum L.). Journal of Chemical Ecology. 2006;32(5):1101-1109.
  116. 116. Ciegler A, Lillehoj EB, Peterson RE, Hall HH. Microbial detoxification of aflatoxin. Applied Microbiology. 1966;14(6):934-939.
  117. 117. Lillehoj EB, Ciegler A, Hall, HH. Aflatoxin B1 uptake by Flavobacterium aurantiacum and resulting toxic effects. Journal of Bacteriology. 1967;93(1):464-471.
  118. 118. Line JE, Brackett RE. Role of toxin concentration and second carbon source in microbial transformation of aflatoxin B1 by Flavobacterium aurantiacum. Journal of Food Protection. 1995;58(9):1042-1044.
  119. 119. Teniola OD, Addo PA, Brost IM, Färber P, Jany KD, Alberts JF, van Zyl WH, Steyn PS, Holzapfel WH. Degradation of aflatoxin B 1 by cell‐free extracts of Rhodococcus erythropolis and Mycobacterium fluoranthenivorans sp. nov. DSM44556 T. International Journal of Food Microbiology. 2005;105(2):111-117.
  120. 120. Nout MJR. Effect of Rhizopus and Neurospora spp. on growth of Aspergillus flavus and A. parasiticus and accumulation of aflatoxin B1 in groundnut. Mycological Research. 1989;93(4):518-523.
  121. 121. Oliveira CAF, Jager AV, Corassin CH, Bovo F, Reddy KR. Recent trends in microbiological decontamination of aflatoxins in foodstuffs. In: INTECH Open Access Publisher. Croatia, Rijeka; 2013.
  122. 122. Nout MJR, Motarjemi Y. Assessment of fermentation as a household technology for improving food safety: A joint FAO/WHO workshop. Food Control. 1997;8(5-6):221-226.
  123. 123. Santin E, Paulillo AC, Maiorka A, Nakaghi LSO, Macari M, Silva AVF, Alessi AC. Evaluation of the efficacy of Saccharomyces cerevisiae cell wall to ameliorate the toxic effects of aflatoxin in broilers. International Journal of Poultry Science. 2003;2(5):341-344.
  124. 124. Shetty PH, Jespersen L. Saccharomyces cerevisiae and lactic acid bacteria as potential mycotoxin decontaminating agents. Trends in Food Science & Technology. 2006;17(2):48-55.
  125. 125. Çelýk K, Denlý M, Savas T. Reduction of toxic effects of aflatoxin B1 by using baker yeast (Saccharomyces cerevisiae) in growing broiler chicks diets. Revista Brasileira de Zootecnia. 2003;32(3):615-619.
  126. 126. Stanley VG, Ojo R, Woldesenbet S, Hutchinson DH, Kubena LF. The use of Saccharo-myces cerevisiae to suppress the effects of aflatoxicosis in broiler chicks. Poultry science. 1993;72(10):1867-1872.
  127. 127. Sampaio Baptista A, Horii J, Antonia Calori‐Domingues M, Micotti da Glória E, Mastrodi Salgado J, Roberto Vizioli M. The capacity of manno‐oligosaccharides, thermolysed yeast and active yeast to attenuate aflatoxicosis. World Journal of Microbiology and Biotechnology. 2004;20(5):475-481.
  128. 128. Devegowda G, Aravind BIR, Morton MG. Saccharomyces cerevisiae and mannanoligosaccharides to counteract aflatoxicosis in broilers. In: Proceedings of Australian Poultry Science Symposium Sydney. 1996;103:106.
  129. 129. Karaman M, Basmacioglu H, Ortatatli M, Oguz H. Evaluation of the detoxifying effect of yeast glucomannan on aflatoxicosis in broilers as assessed by gross examination and histopathology. British Poultry Science. 2005;46(3):394-400.
  130. 130. Thompson ED, Knights BA, Parks LW. Identification and properties of a sterol‐binding polysaccharide isolated from Saccharomyces cerevesiae. Biochimica et Biophysica Acta (BBA)‐General Subjects. 1973;304(1):132-141.
  131. 131. El‐Nezami H, Kankaanpaa P, Salminen S, Ahokas J. Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B 1. Food and Chemical Toxicology. 1998;36(4):321-326.
  132. 132. Peltonen K, El‐Nezami H, Haskard C, Ahokas J, Salminen, S. Aflatoxin B1 binding by dairy strains of lactic acid bacteria and bifidobacteria. Journal of Dairy Science. 2001;84(10):2152-2156.
  133. 133. Turbic A, Ahokas JT, Haskard, CA. Selective in vitro binding of dietary mutagens, individually or in combination, by lactic acid bacteria. Food Additives & Contaminants. 2002;19(2):144-152.
  134. 134. Haskard C, Binnion C, Ahokas J. Factors affecting the sequestration of aflatoxin by Lactobacillus rhamnosus strain GG. Chemico‐Biological Interactions. 2000;128(1):39-49.
  135. 135. Lahtinen SJ, Haskard CA, Ouwehandz AC, Salminenz SJ, Ahokasy JT. Binding of aflatoxin B1 to cell wall components of Lactobacillus rhamnosus strain GG. Food Additives and Contaminants. 2004;21:158-164.
  136. 136. Haskard CA, El‐Nezami HS, Kankaanpää PE, Salminen S, Ahokas JT. Surface binding of aflatoxin B1 by lactic acid bacteria. Applied and Environmental Microbiology. 2001;67(7):3086-3091.
  137. 137. Megalla SE, Hafez AH. Detoxification of aflatoxin B1 by acidogenous yoghurt. Mycopathologia. 1982;77(2):89-91.
  138. 138. Megalla SE, Mohran MA. Fate of a atoxin B‐1 in fermented dairy products. Mycopathologia. 1984;88:27-29.
  139. 139. Liu DL, Yao DS, Liang R, Ma L, Cheng WQ, Gu LQ. Detoxification of aflatoxin B 1 by enzymes isolated from Armillariella tabescens. Food and Chemical Toxicology. 1998;36(7):563-574.
  140. 140. Liang ZH, Li JX, He YL, Guan S, Wang N, Ji C, Niu TG. AFB1 bio‐degradation by a new strain‐Stenotrophomonas sp. Agricultural Sciences in China. 2008;7(12):1433-1437.
  141. 141. Teunisson DJ, Robertson JA. Degradation of pure aflatoxins by Tetrahymena pyriformis. Applied Microbiology. 1967;15(5):1099-1103.
  142. 142. Detroy RW, Hesseltine CW. Transformation of aflatoxin B1 by steroid‐hydroxylating fungi. Canadian Journal of Microbiology. 1969;15(6):495-500.
  143. 143. Schultz DL, Luedecke LO. Effect of neutral fats and fatty acids on aflatoxin production. Journal of Food Protection. 1977;40(5):304-308.
  144. 144. Hamid AB, Smith JE. Degradation of aflatoxin by Aspergillus flavus. Microbiology. 1987;133(8):2023-2029.
  145. 145. Huwig A, Freimund S, Käppeli O, Dutler H. Mycotoxin detoxication of animal feed by different adsorbents. Toxicology Letters. 2001;122(2):179-188.
  146. 146. Lewis SJ, Freedman AR. Review article: The use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Alimentary Pharmacology & Therapeutics. 1998;12(9):807-822.
  147. 147. Madrigal‐Santillán E, Madrigal‐Bujaidar E, Márquez‐Márquez R, Reyes A. Antigeno-toxic effect of Saccharomyces cerevisiae on the damage produced in mice fed with aflatoxin B 1 contaminated corn. Food and Chemical Toxicology. 2006;44(12):2058-2063.
  148. 148. Diaz DE, Hagler WM, Hopkins BA, Whitlow LW. Aflatoxin binders I: in vitro binding assay for aflatoxin B1 by several potential sequestering agents. Mycopathologia. 2003;156(3):223-226.
  149. 149. Kankaanpää P, Tuomola E, El‐Nezami H, Ahokas J, Salminen SJ. Binding of aflatoxin B1 alters the adhesion properties of Lactobacillus rhamnosus strain GG in a Caco‐2 model. Journal of Food Protection. 2000;63(3):412-414.
  150. 150. Gratz S, Mykkänen H, Ouwehand AC, Juvonen R, Salminen S, El‐Nezami H. Intestinal mucus alters the ability of probiotic bacteria to bind aflatoxin B1 in vitro. Applied and Environmental Microbiology. 2004;70(10):6306-6308.
  151. 151. El‐Nezami H, Mykkänen H, Kankaanpää P, Salminen S, Ahokas J. Ability of Lactobacillus and Propionibacterium strains to remove aflatoxin B1 from the chicken duodenum. Journal of Food Protection. 2000;63(4):549-552.
  152. 152. Bolognani F, Rumney CJ, Rowland IR. Influence of carcinogen binding by lactic acid‐producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens. Food and Chemical Toxicology. 1997;35(6):535-545.
  153. 153. Basappa SC, Shantha T. Methods for detoxification of aflatoxins in foods and feeds: A critical appraisal. Journal of Food Science and Technology. 1996;33(2):95-107.
  154. 154. Salhab AS, Edwards GS. Comparative in vitro metabolism of aflatoxicol by liver preparations from animals and humans. Cancer Research. 1977;37(4):1016-1021.
  155. 155. Roebuck BD, Wogan GN. Species comparison of in vitro metabolism of aflatoxin B1. Cancer Research. 1977;37(6):1649-1656.
  156. 156. Roebuck BD, Siegel WG, Wogan GN. In vitro metabolism of aflatoxin B2 by animal and human liver. Cancer Research. 1978;38(4):999-1002.
  157. 157. Chipley JR, Mabee MS, Applegate KL, Dreyfuss M.S. Further characterization of tissue distribution and metabolism of [14C] aflatoxin B1 in chickens. Applied Microbiology. 1974;28(6):1027-1029.
  158. 158. Donnelly PJ, Stewart RK, Ali SL, Conlan AA, Reid KR, Petsikas D, Massey TE. Biotransformation of aflatoxin B1 in human lung. Carcinogenesis. 1996;17(11):2487-2494.
  159. 159. Yoshizawa H, Uchimaru R, Kamataki T, Kato R, Ueno Y. Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P‐450 system of rat liver. Cancer Research. 1982;42(3):1120-1124.
  160. 160. Sánchez‐González L, Cháfer M, González‐Martínez C, Chiralt A, Desobry S. Study of the release of limonene present in chitosan films enriched with bergamot oil in food simulants. Journal of Food Engineering. 2011;105(1):138-143.
  161. 161. Saraf S. Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010;81(7):680-689.
  162. 162. McClements DJ, Rao J. Food‐grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity. Critical Reviews in Food Science and Nutrition. 2011;51(4):285-330.
  163. 163. Chang Y, McLandsborough L, McClements DJ. Physicochemical properties and antimicrobial efficacy of carvacrol nanoemulsions formed by spontaneous emulsification. Journal of Agricultural and Food Chemistry. 2013;61(37):8906-8913.
  164. 164. Gurr SJ, Rushton PJ. Engineering plants with increased disease resistance: What are we going to express? Trends in Biotechnology. 2005;23(6):275-282.

Written By

Fei Tian and Hyang Sook Chun

Submitted: 26 November 2016 Reviewed: 08 March 2017 Published: 30 August 2017